2m 2m 2m 2m 2m 2m 2m
DIAMEDICA THERAP (DMAC)
NASDAQ
$7.49$0.00 (0.00%)
Price as of Jul 13, 2026 6:18 PM EDT- $413.3MMarket Cap
- 86.78%1-Year Change
- BiotechnologyIndustry
DIAMEDICA THERAP (DMAC)
$7.49$0.00 (0.00%)
DMAC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.49 | ||
Change | -$0.18 (-2.35%) | ||
Open | $7.79 | ||
High | $7.79 | ||
Low | $7.35 | ||
Previous Close | $7.67 | ||
Volume | 168,130 | ||
30-Day Average Volume | 277,504 | ||
1-Week Change | -6.49% | ||
1-Month Change | 32.57% | ||
1-Year Change | 86.78% | ||
3-Year Change | 92.05% | ||
5-Year Change | 88.66% | ||
Fundamentals | |||
Shares Outstanding | 53.9M | ||
Total Assets | $53.1M | ||
Market Cap | $413.3M | ||
Enterprise Value | $408.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$10.0M | ||
Free Cash Flow | -$9.1M | ||
EBIT | -$10.0M | ||
EBITDA | -$10.0M | ||
Net Working Capital | $46.6M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -41 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 9 | ||
P/E | -40 | ||
PEG | 3 | ||
Price/Free Cash Flow | -45 | ||
Price/Operating Cash Flow | -46 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue